Biomemory Acquires Catalog Tech, Accelerating DNA Storage

Biomemory, a French startup at the forefront of DNA data storage, has significantly bolstered its capabilities by acquiring the assets of Catalog Technologies. This integration brings together Catalog's foundational intellectual property, including patents, printing, reading, and computing technologies. The combined entity is focused on industrializing DNA storage solutions, with a roadmap that includes offering advanced search and computing functions within DNA data structures.

Olivier Lauvray, VP of Industrialization at Biomemory, indicated that the company is pursuing the development of these value-added capabilities. Biomemory plans to launch its first end-to-end commercial DNA Data Storage solutions before the end of 2026. The company's strategy involves a rigorous qualification process to ensure reliability and robustness, with a focus on a block-by-block enzymatic DNA assembly technology for scalability and cost reduction.

Biomemory anticipates deploying rackable data storage appliances suitable for data centers by 2030-2031. These appliances will feature a compact 19" 42U form factor and aim for interoperability and high resilience. In the interim, Biomemory will offer solutions through clusters of equipment operated in a hybrid-cloud configuration to meet market demand, with projections to reach a cost of a few dollars per terabyte upon mass deployment.